Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 3 | Alzheimer's Research & Therapy

Fig. 3

From: Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum

Fig. 3

Association of synaptic markers with core AD biomarkers in CSF. CSF VAMP-2 (A), SNAP-25 (B) and Ng (C) are plotted against core CSF AD biomarkers (Aβ42:40 ratio, p-tau, total tau) in cognitively healthy controls and AD patients. Linear regression lines are shown for each group. Shaded areas represent standard error of the regression lines

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193